I understand your point DrT, but there maybe some SH who would accept and maybe want an exit at an ASX200 & 300 market cap....Also perhaps our low SOI and concentration of ownership maybe inhibit this somewhat. Lastly, surely we would need some significant SP appreciation to guard against being lowballed by big pharma.
(20min delay)